Compounded Semaglutide with BPC-157 or B12 is a glucagon-like peptide-1 (GLP-1) receptor agonist, also referred to as an incretin mimetic. It works to enhance the growth of beta cells in the pancreas, which are sites of insulin production. This means your body has improved control over blood sugar spikes. Semaglutide with BPC-157 or B12 delays gastric emptying, which reduce appetite, improve control of eating, and reduce food cravings.
In July of 2022, a study was published describing the weight loss benefits of tirzepatide. Participants in the study lost on average, over 20% of their body weight. Under the brand name, this can be expensive, unavailable, or not covered by insurance. Tirzepatide, the active ingredient, is compounded with vitamin B12 at a fraction of the cost and offers the same weight loss benefit.